Roberta Thomas

Anti-tumor Activity of the Type I PRMT Inhibitor, GSK3368715, Synergizes with PRMT5 Inhibition through MTAP Loss

Andrew Fedoriw, Satyajit Rajapurkar, Shane W. O’Brien et al. · Cancer Cell · 2019 · 333 citations · Full text

Cancer Research, Mtap Loss, Medicine +10

Preliminary Comparison of Quantity, Quality, and Microarray Performance of RNA Extracted From Formalin-fixed, Paraffin-embedded, and Unfixed Frozen Tissue Samples

Marshall S. Scicchitano, Deidre A. Dalmas, Melissa A. Bertiaux et al. · Journal of Histochemistry & Cytochemistry · 2006 · 107 citations · Full text

Pharmacological evidence for complex and multiple site interaction of CXCR4 with SDF-1α: implications for development of selective CXCR4 antagonists

Shalley K. Gupta, Kodandaram Pillarisetti, Roberta Thomas et al. · Immunology Letters · 2001 · 82 citations

Molecular Pharmacology, Signal Transduction, Medicine +10

Inhibition of ALK5 Signaling Induces Physeal Dysplasia in Rats

Kendall S. Frazier, Roberta Thomas, Marshall S. Scicchitano et al. · Toxicologic Pathology · 2007 · 47 citations

Cell Death, Pathology, Bmp7 Expression +16

Nonclinical Safety Biomarkers of Drug-induced Vascular Injury

Igor Mikaelian, Mark J. Cameron, Deidre A. Dalmas et al. · Toxicologic Pathology · 2014 · 46 citations

Immunology, Cardiovascular Toxicity, Inflammation +17